-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster III

Symposia: Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Lauren E. Merz, MD, MSc1,2, Yating Wang, MS3*, Elad Sharon, MD, MPH4*, Thomas P Walsh5*, Gregory Abel, MD, MPH5 and Andrew Hantel, MD6

1Division of Hematology/Oncology, Mass General Brigham, Boston, MA
2Department of Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA
3Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
4Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
6HMS Center for Bioethics, Dana-Farber Cancer Institute, Boston, MA

Elizabeth A. Griffiths, MD1, Andrew Messali2*, Mohammed Mahdi2*, Maral DerSarkissian3*, Rose Chang3*, Brendan Rabideau3* and David Dingli, MD, PhD4

1Roswell Park Comprehensive Cancer Center, Buffalo, NY
2Alexion, AstraZeneca Rare Disease, Boston, MA
3Analysis Group, Inc., Boston, MA
4Mayo Clinic, Rochester, MN

Juliana Schwaab, MD1*, Paul Dolin2*, Priya Jain2, Jennifer Rowell3*, Chris Edmonds4*, Josepine Persson5*, Daniel Mascia6*, Tia Pennant6*, Fritha Hennessy6* and Stephanie Yanjing Chen7*

1Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany
2BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom
3Market Access and Pricing, AstraZeneca, Cambridge, United Kingdom
4Market Access and Pricing, AstraZeneca, Gaithersburg, MD
5Market Access and Pricing, AstraZeneca, Gothenburg, Sweden
6Adelphi Real World, Bollington, United Kingdom
7BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD

Emma P Deloughery, MD1 and Thomas G Deloughery, MD2

1Oregon Health & Science University, Portland, OR
2Division of Hematology and Medical Oncology, Oregon Health and Science Univ., Portland, OR

Víctor Jiménez-Yuste, MD, PhD1*, Cléa Percier, PharmD2*, Naveen Shridhar, MBBS, PhD3*, Neil Reynolds4*, Olivera Rajkovic-Hooley4*, Thom Dewar4* and Giancarlo Castaman5*

1Hospital Universitario La Paz, Universidad Autónoma de Madrid, Madrid, Spain
2Novo Nordisk Health Care AG, Zürich, Switzerland
3Novo Nordisk Service Centre India Private Limited, Bangalore, India
4Adelphi Real World, Bollington, United Kingdom
5Center for Bleeding Disorders and Coagulation, Careggi University Hospital, Florence, Italy

Michael Recht, MD, PhD, MBA1,2*, Hanna Salehi, MSc3*, Chris Blazos, BSc4*, Sophie Lai, BSc4*, Ella Morton, BSc4*, Lucy Lee, PharmD, MPH5*, Juliana M.L. Biondo, MD5 and Janet S Lee5*

1National Bleeding Disorders Foundation, New York, NY
2Yale School of Medicine, New Haven, CT
3Adelphi Real World, Bollington, United Kingdom
4Adelphi Real World, Macclesfield, United Kingdom
5Genentech, Inc., South San Francisco, CA

Claire Booth, MBBS, PhD1,2*, Patrick Gilbert3*, Luuk Gras4*, Hawazen Alsaedi5*, Amir Ali Hamidieh6*, Mor Seny Gueye7*, Mary Slatter, MD8*, Ashrafsadat Mousavi9*, Amos Toren10*, Musa Karakukcu, MD11*, Abdelghani Tbakhi12*, Polina Stepensky13*, Gulyuz Ozturk14*, Peter Bader15, Henrik Sengeloev16*, Tayfun Güngör17*, R.F. Wynn18*, Franco Locatelli, MD19, Maria Chitty-Lopez, MD20*, Joana E Matos20*, Stuart Turner20*, Gayatri R Rao, MD, JD20*, Jonathan D Schwartz, MD20, Michael H Albert21* and Bénédicte Neven22*

1University College London Great Ormond Street Institute of Child Health, London, United Kingdom
2Department of Paediatric Immunology and Gene Therapy, Great Ormond Street Hospital NHS Trust, London, United Kingdom
3EBMT Leiden Study Unit, Leiden, Netherlands
4EBMT, Leiden, Netherlands
5King Faisal Specialist Hospital and Research Centre, Riyadh, SAU
6Pediatric Cell and Gene Therapy Research Centre, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran (Islamic Republic of)
7Hospital Necker-Enfants Malades, Paris, France
8Paediatric Stem Cell Transplant Unit, Great North Children’s Hospital, Newcastle Upon Tyne, United Kingdom
9Shariati Hospital, Teheran, Iran (Islamic Republic of)
10Sheba Medical Center, Tel-Hashomer, Israel
11Pediatri Hematoloji Onkoloji Başkanı, Erciyes Üniversitesi, Kayseri, Turkey
12King Hussein Cancer Foundation and Center, Amman, Jordan
13Hadassah University Hospital, Jerusalem, Israel
14Acibadem Saglik Hizmetleri ve Ticaret Anonim Sirketi, Istanbul, TUR
15Universitätsklinikum Frankfurt Goethe-Universität, Frankfurt, Germany
16Rigshospitalet, Copenhagen, Denmark
17Hematology/Oncology/Immunology, Gene Therapy, and Stem Cell Transplantation, University Children's Hospital Zurich-Eleonore Foundation & Children's Research Center, Zürich, Switzerland
18Royal Manchester Children's Hospital, Manchester, United Kingdom
19IRCCS Ospedale Pediatrico Bambino Gesù, Catholic University of the Sacred Heart, Rome, Italy
20Rocket Pharmaceuticals, Inc., Cranbury, NJ
21Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
22Unité d'Immuno-Hématologie et Rhumatologie Pédiatrique, Assistance Publique-Hôpitaux de Paris, Paris, France

Elizabeth Bowhay-Carnes, MD1*, Yuliya Kreychman2*, Lucas Buxman3* and Leslie Todd2*

1Division of Hematology-Oncology, Mays Cancer Center at UT Health MD Anderson, San Antonio, TX
2Rigel Pharmaceuticals, Inc., South San Francisco, CA
3Claritas Rx, Inc., South San Francisco

Maya Birhiray, MS*, Sam Ranger, M.S.* and Ruemu Birhiray

Indy Hematology Education Inc., Carmel, IN

Valeria Merla, MPH1*, Sheena Thakkar, MPH1*, Jasmine Healy, PhD2*, Ella Morton, BSc3*, Kieran Wynne-Cattanach, MSc3*, Nathan Ball, BSc3*, Sophie Lai, BSc3*, Chris Blazos, BSc3* and Hanna Salehi, MSc3*

1Pfizer Inc, New York, NY
2Pfizer Canada ULC, Kirkland, QC, Canada
3Adelphi Real World, Bollington, United Kingdom

Meera Karunakaran1,2*, Fatema Hossain1,2*, Erin Jamula, MSc1,2*, Ishac Nazy, PhD1,2,3 and Donald Arnold, MD1,2

1Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, ON, Canada
2Department of Medicine, McMaster University, Hamilton, ON, Canada
3Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada

Cho Han Chiang1*, Shuwen Lin, MD2*, Yu-Cheng Chang, MD3*, Junmin Song, MD4, Kuan-Yu Chi, MD4*, Nutchapon Xanthavanij, MD5*, Yu Chang, MD6*, Cho-Hung Chiang, MD7* and Xiaocao/Haze Xu, MBBS8*

1Department of Medicine, Mount Auburn Hospital, Cambridge, MA
2Montefiore Medical Center, Montefiore Einstein Cancer Center, Bronx, NY
3Department of Medicine, Danbury Hospital, Danbury, CT
4Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY
5Mount Auburn Hospital, Cambridge, MA
6Section of Neurosurgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
7National Taiwan University Hospital, Taipei, Taiwan
8University of Vermont Medical Center, Burlington, VT

Jens Panse, MD1, Juan Carlos Vallejo Llamas, MD2*, Koo Wilson, MSc3*, Zalmai Hakimi, PhD3*, Barbara Czech, PhD3*, Brianne Kerr, BSc4*, Sam Williamson, BSc4*, Jade Garratt-Wheeldon, BSc4*, Yasmin Taylor, MSc, BSc4*, Niall Hatchell, MSc, BSc4* and Christopher Patriquin, MD, MSc, FRCPC5

1Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany & Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen, Aachen, Germany
2University Clinical Hospital of Santiago, Santiago De Compostela, Spain
3Swedish Orphan Biovitrum AB, Stockholm, Sweden
4Adelphi Real World, Bollington, United Kingdom
5Division of Medical Oncology & Hematology, University Health Network, Toronto, ON, Canada

Kristi Upadhyaya1*, Xiaoying Chen2*, Alok A. Khorana, MD1 and Dana Elizabeth Angelini, MD1

1Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
2Cleveland Clinic, Quantitative Health Sciences, Lerner Research Institute, Cleveland, OH

Sumera Ackbarali1*, Tariqa Ackbarali, MSc2*, Katie Kowalski, MPH3*, Shirley D'Sa, FRCP FRCPath MD(Res)4*, Carlos M de Castro, MD5, Satheesh Chonat, MD6 and Catherine M. Broome, MD7

1PlatformQ Health Education, LLC, Lake Worth, FL
2PlatformQ Health, Lake Worth, FL
3National Organization for Rare Disorders, Danbury, CT
4University College London Hospitals NHS Foundation Trust, London, United Kingdom
5Duke University, Durham, NC
6Cincinnati Children's Hospital, Atlanta, GA
7Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, DC

Alexis Brantley, MD1*, Nali Gillespie, M.D.2*, Morgan Viviano, MD1*, Leah Smith, DO1*, Zhide Feng, PhD3*, Maria C. Velez-Yanguas, MD4 and Zachary LeBlanc, MD5*

1Louisiana State University Health Sciences Center School of Medicine, New Orleans
2Louisiana State University Health Sciences Center School of Medicine, New Orleans, LA
3Department of Biostatistics, Louisiana State University Health Sciences Center, New Orleans
4Division of Pedatric Hematology and Oncology, Louisiana State University Health Sciences Center School of Medicine, New Orleans, LA
5Division of Pediatric Hematology and Oncology, Louisiana State University Health Sciences Center School of Medicine, New Orleans, LA

Alexander J Xiang1*, Sarah Sadafi, BHSc2*, Rachael Principato3*, Asim Shaikh, BHSc2*, Mehrad Nowrouzi2*, Allen Li, MD4, Ali Eshaghpour, MD5 and Mark A. Crowther, MD, MSc, FRSC, FRCPC, LLM5

1Department of Medicine, McMaster University, Kitchener, ON, Canada
2McMaster University, Hamilton, Canada
3University of Guelph, Guelph, Canada
4Department of Vascular Surgery, University of Toronto, Toronto, ON, Canada
5Department of Medicine, McMaster University, Hamilton, Canada

Priya Jain1, Jennifer Rowell2*, Chris Edmonds3*, Michael Stokes4*, Ning Ding5* and Stephanie Yanjing Chen6*

1BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom
2Market Access and Pricing, AstraZeneca, Cambridge, United Kingdom
3Market Access and Pricing, AstraZeneca, Gaithersburg, MD
4Data Analytics, Evidera, Saint-Laurent, QC, Canada
5Data Analytics, Evidera, Bethesda, MD
6BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD

Amber Afzal, MD, MSc1, Brian F. Gage, MD, MSc2*, Luo Suhong3* and Kristen M. Sanfilippo, MD4,5

1Washington University School of Medicine St Louis, Saint Louis, MO
2Washington University School of Medicine in St. Louis, St Louis, MO
3Veterans Health Administration, Saint Louis, MO
4Washington University School of Medicine St Louis, Chesterfield, MO
5St Louis Veterans Affairs Medical Center, Saint Louis, MO

*signifies non-member of ASH